Ease your regulatory compliance efforts in 2023
REAL Solutions Group's HealthRISC (Regulatory Intelligence and Simplified Compliance): Drug Supply Chain is a monthly reporting service engineered to meet your regulatory and policy tracking needs. Our research includes all state and federal legislative activity, administrative rule promulgation, and medical and pharmacy board activity to ensure that you don't miss a beat.
Custom reporting, timely updates
REAL Solutions Group's monthly report, HealthRISC: Drug Supply Chain, captures any and all regulatory changes that relate to or impact 503B Outsourcing Facilities, NABP Drug Distributor Accreditation (DDA), Manufacturers, Reverse Distributors, Third Party Logistics Providers, Virtual Wholesalers, or Wholesale Drug Distributors. Our team of skilled experts works hard to research the regulatory landscape so you can be prepared for what’s next. We take complex search results and distill them down into actionable insights.
See what HealthRISC can do for you
Each monthly report captures any and all regulatory changes including the following:
Newly enacted federal and state statutes;
Relevant regulatory board, agency and department meeting minutes referencing policy and regulation;
Newly effective federal and state administrative rules and regulations
Novel disciplinary actions; and
State and federal regulatory agency policy statements, directives, and guidance for all 50 states and D.C.
Federal agency guidance
Interested in our services?
To discuss how our services can support your organization, complete the contact form and a representative will be in touch shortly.
REAL Solutions Group
p: (847) 261-4004